Harper Investing’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ATO
Harper Investing's MRK Position: Q2 2026 in Review
Harper Investing reduced its Merck (MRK) stake by 0.11% in Q2 2026, selling an estimated $2.93K and leaving 21,760 shares worth $2.8M. The position accounts for 0.94% of the portfolio, ranked #35.
Harper Investing first reported a position in MRK in Q1 2022 and has held it in 18 quarters since. The position peaked at $5.05M in Q4 2025. 1,495 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Harper Investing held 21,760 shares of Merck worth $2.8M as of Q2 2026.
- Harper Investing sold 25 Merck shares in Q2 2026, an estimated $2.93K.
- Merck made up 0.94% of Harper Investing's portfolio in Q2 2026, its #35 holding.
- Harper Investing first reported a position in Merck in Q1 2022 and has held it in 18 quarters since.
- Harper Investing's Merck position peaked at $5.05M in Q4 2025.
- 1,495 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Harper Investing's 13F filing for Q2 2026, filed 22 Jul 2026.